2039 related articles for article (PubMed ID: 28619367)
21. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
22. High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.
Härdtner C; Mörke C; Walther R; Wolke C; Lendeckel U
Int J Mol Med; 2013 Oct; 32(4):795-804. PubMed ID: 23942780
[TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
24. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
25. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.
Schindler C; Bramlage P; Kirch W; Ferrario CM
Vasc Health Risk Manag; 2007; 3(1):125-37. PubMed ID: 17583183
[TBL] [Abstract][Full Text] [Related]
26. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
Borghi C; ; Rossi F;
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
[TBL] [Abstract][Full Text] [Related]
27. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
28. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
Huber K; Pachinger O; Pichler M; Klein W
Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
[TBL] [Abstract][Full Text] [Related]
30. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.
Zhuo JL; Ferrao FM; Zheng Y; Li XC
Front Endocrinol (Lausanne); 2013; 4():166. PubMed ID: 24273531
[TBL] [Abstract][Full Text] [Related]
31. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
32. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
Moreira FRC; de Oliveira TA; Ramos NE; Abreu MAD; Simões E Silva AC
Mol Biol Rep; 2021 Sep; 48(9):6619-6629. PubMed ID: 34417705
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Galandrin S; Denis C; Boularan C; Marie J; M'Kadmi C; Pilette C; Dubroca C; Nicaise Y; Seguelas MH; N'Guyen D; Banères JL; Pathak A; Sénard JM; Galés C
Hypertension; 2016 Dec; 68(6):1365-1374. PubMed ID: 27698068
[TBL] [Abstract][Full Text] [Related]
34. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the renin-angiotensin system (RAS) in BeWo and HTR-8/SVneo trophoblast cell lines.
Wang Y; Pringle KG; Chen YX; Zakar T; Lumbers ER
Placenta; 2012 Aug; 33(8):634-9. PubMed ID: 22647832
[TBL] [Abstract][Full Text] [Related]
36. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Kanda T; Itoh H
Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
[TBL] [Abstract][Full Text] [Related]
37. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
38. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system.
Cui C; Xu P; Li G; Qiao Y; Han W; Geng C; Liao D; Yang M; Chen D; Jiang P
Redox Biol; 2019 Sep; 26():101295. PubMed ID: 31421410
[TBL] [Abstract][Full Text] [Related]
40. Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.
Gonzalez AA; Prieto MC
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):191-200. PubMed ID: 25780059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
